January 25, 2024 - 11:00AM ET
During this webinar, we will explore the possibilities offered by a phase-specific regulatory strategy for overcoming challenges associated with the CMC (Chemistry, Manufacturing, and Controls) approach for ATMPs. Employing a phase-specific approach is crucial for optimizing time and cost savings in regulatory compliance while effectively managing expectations during each stage of clinical development
Webinar Learning Objectives:
- Outline details for taking a phase appropriate approach
- Discuss specification and stability strategies for early phase development
- Discuss ways Sponsors can ensure their phase-appropriate approach will be accepted